Dequalinium chloride use in adult Spanish women with bacterial vaginosis: an observational study

References

• Abbai NS, Reddy T, Ramjee G. 2016. Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa. International Journal of STD & AIDS 27:1283–1288.
   PubMed Web of Science ®Google Scholar
• Allsworth JE, Peipert JF. 2007. Prevalence of bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Obstetrics and Gynecology 109:114–120.
   PubMed Web of Science ®Google Scholar
• Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, et al. 2013. The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One 8:e74378.
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, et al. 2006. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. The Journal of Infectious Diseases 193:1478–1486.
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Walker J, Fairley CK, Chen MY, Tabrizi SN, Donovan B, et al. 2013. Prevalent and incident bacterial vaginosis are associated with sexual and contraceptive behaviours in young Australian women. PLoS One 8:e57688.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2015. Sexually transmitted diseases treatment guidelines. Bacterial Vaginosis. [Accessed 2020 Apr 16]. Available from https://www.cdc.gov/std/tg2015/bv.htm
   Google Scholar
• Chavoustie SE, Eder SE, Koltun WD, Lemon TR, Mitchell C, Nyirjesy P, et al. 2017. Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers. Int J Gynaecol Obstet 137:107–109.
   PubMed Web of Science ®Google Scholar
• Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D. 2012. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. Jama 307:2079–2086.
   PubMed Web of Science ®Google Scholar
• Dequalinium for Bacterial Vaginosis. 2017. Drug & Therapeutics Bulletin 55:54–57.
   PubMedGoogle Scholar
• Desseauve D, Chantrel J, Fruchart A, Khoshnood B, Brabant G, Ancel PY, Subtil D. 2012. Prevalence and risk factors of bacterial vaginosis during the first trimester of pregnancy in a large French population-based study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 163:30–34.
   PubMed Web of Science ®Google Scholar
• Donders GG, Zodzika J, Rezeberga D. 2014. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opinion on Pharmacotherapy 15:645–657.
   PubMed Web of Science ®Google Scholar
• Huang H, Song L, Zhao W. 2014. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Archives of Gynecology and Obstetrics 289:1225–1234. 2014
   PubMed Web of Science ®Google Scholar
• Jung HS, Ehlers MM, Lombaard H, Redelinghuys MJ, Kock MM. 2017. Etiology of bacterial vaginosis and polymicrobial biofilm formation. Critical Reviews in Microbiology 43:651–667.
   PubMed Web of Science ®Google Scholar
• Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE. 2007. The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sexually Transmitted Diseases 34:864–869.
   PubMed Web of Science ®Google Scholar
• Larsson PG, Forsum U. 2005. Bacterial vaginosis-a disturbed bacterial flora and treatment enigma. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 113:305–316.
   PubMed Web of Science ®Google Scholar
• Li XD, Tong F, Zhang XJ, Pan WJ, Chen ML, Wang CC, et al. 2015. Incidence and risk factors of bacterial vaginosis among pregnant women: a prospective study in Maanshan city, Anhui Province, China. The Journal of Obstetrics and Gynaecology Research 41:1214–1222.
   PubMed Web of Science ®Google Scholar
• Marconi C, Duarte MT, Silva DC, Silva MG. 2015. Prevalence of and risk factors for bacterial vaginosis among women of reproductive age attending cervical screening in southeastern Brazil. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 131:137–141.
   PubMed Web of Science ®Google Scholar
• Mendling W, Martius J, Hoyme UB. 2014. S1-Guideline on Bacterial Vaginosis in Gynecology and Obstetrics: Long version - AWMF Guideline, registration no. 015/028, July 2013 Langfassung - AWMF-Register Nr. 015/028, Juli 2013. Geburtshilfe Und Frauenheilkunde 74:51–54.
   PubMed Web of Science ®Google Scholar
• Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P. 2016. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Archives of Gynecology and Obstetrics 293:469–484.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Marrazzo J. 2014. Bacterial vaginosis and the cervicovaginal immune response. American Journal of Reproductive Immunology (New York, N.Y: 1989) 71:555–563.
   PubMed Web of Science ®Google Scholar
• Nasioudis D, Linhares IM, Ledger WJ, Witkin SS. 2017. Bacterial vaginosis: a critical analysis of current knowledge. BJOG: An International Journal of Obstetrics and Gynaecology 124:61–69.
   PubMed Web of Science ®Google Scholar
• Onderdonk AB, Delaney ML, Fichorova RN. 2016. The human microbiome during bacterial vaginosis. Clinical Microbiology Reviews 29:223–238.
   PubMed Web of Science ®Google Scholar
• Petersen EE, Weissenbacher ER, Hengst P, Spitzbart H, Weise W, Wolff F, et al. 2002. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study. Arzneimittel-Forschung 52:706–715.
   PubMed Web of Science ®Google Scholar
• Reichman O, Luwisch H, Sela HY, Samueloff A. 2017. Genital discomfort: yeast, trichomonas and bacterial vaginosis are only the tip of the iceberg. European Journal of Obstetrics & Gynecology and Reproductive Biology 214:200–201.
   PubMed Web of Science ®Google Scholar
• Rugpao S, Sriplienchan S, Rungruengthanakit K, Lamlertkittikul S, Pinjareon S, Werawatakul Y, et al. 2008. Risk factors for bacterial vaginosis incidence in young adult Thai women. Sexual Transmitted Diseases 35:643–648.
   PubMed Web of Science ®Google Scholar
• Sobel J, Peipert JF, McGregor JA, Livengood C, Martin M, Robbins J, Wajszczuk CP. 2001. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology 9:9–15.
   PubMedGoogle Scholar
• Spanish Gynecology and Obstetrics Society (SEGO). 2018. Guidelines on diagnosis and treatment of vulvovaginal infections. www.sego.es
   Google Scholar
• Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dörffel Y, Scholze J, et al. 2008. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. American Journal of Obstetrics & Gynecology 198:97 e91–96.
   Web of Science ®Google Scholar
• Verstraelen H, Verhelst R, Roelens K, Temmerman M. 2012. Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review. BMC Infectious Diseases 12:148
   PubMed Web of Science ®Google Scholar
• Weissenbacher ER, Donders G, Unzeitig V, Martinez de Tejada B, Gerber S, Halaška M, Špaček J. 2012. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.Gynecologic and Obstetric Investigation 73:8–15.
   PubMed Web of Science ®Google Scholar